1. Andersson B, Beran M (1980) Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex. Cancer Chemother Pharmacol 4:205?207
2. Andersson B, Beran M, Peterson C, Tribukait B (1982) Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin. Cancer Res 42:178?183
3. Bachur NR, Steele M, Meriwether WD, Hildebrand RC (1976) Cellular pharmacodynamics of several anthracycline antibiotics. J Med Chem 19:651?654
4. DeGregorio MW, Carrera CJ, Klock JC, Pegelow CH, Wilbur JR (1982a) Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia. Cancer Treat Rep 366:2085?2088
5. DeGregorio MW, Carrera CJ, Klock JC, Wilbur JR (1982b) Uptake and metabolism of daunorubicin by human leukemia cells. Cancer Chemother Pharmacol 10:29?32